Click HereTherapeutic Options not on the QTdrugs List
Attention All Commercial Users of QTdrugs Technology
Commercial use or reproduction of the QTdrugs list or other copyrighted content from the CredibleMeds® website is prohibited unless licensed or authorized by AZCERT, Inc. Commercial use by a company's employee(s) or contractor(s) is defined in AZCERT's Terms of Use.
AZCERT's policy defines permissable, non-commercial use as any use by employees of government agencies, academic institutions, not-for-profit entities or self-employed healthcare providers.
Online orders for licenses can be placed here and quotes for licensing fees are available by contacting info@azcert.org.
Prolongation of the QT interval is a well-established risk factor that predicts increased mortality from sudden cardiac death.1 Identification of patients with the highest risk of QT prolongation and associated adverse outcomes has been facilitated…
The QTdrugs List includes three distinct risk categories for Torsades de Pointes (TdP) and QT prolongation but not all drugs in the List should be considered “QT prolonging”.
Because of the inherent complexity of drug-induced QT prolongation and the…
Deutetrabenazine (used to treat tardive dyskinesia) and Dexmedetomidine (a sedative) were removed from the Possible Risk of TdP category and are no longer on the QTdrugs list. Our analysis of new evidence did not support their continued placement on…
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW , Gallo T, Woosley D and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, Inc. 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.
Print
Share
RSS
Donate
